इटली - इतालवी - AIFA (Agenzia Italiana del Farmaco)

isdin s.r.l. - itraconazolo - itraconazolo

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

seagen international gmbh - tucatinibum - compresse rivestite con film - tucatinibum 50 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 9.21 mg, kalium 10.10 mg. - zur behandlung von metastasiertem her2-positivem brustkrebs - synthetika

स्विट्ज़रलैंड - इतालवी - Swissmedic (Swiss Agency for Therapeutic Products)

seagen international gmbh - tucatinibum - compresse rivestite con film - tucatinibum 150 mg, copovidonum, crospovidonum, natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, silica colloidalis anhydrica, cellulosum microcristallinum, magnesii stearas, Überzug: poly(alcohol vinylicus), e 171, macrogolum 4000, talcum, e 172 (flavum), pro compresso obducto corresp. natrium 27.65 mg, kalium 30.29 mg. - zur behandlung von metastasiertem her2-positivem brustkrebs - synthetika

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirali per uso sistemico - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - agenti antineoplastici - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - agenti antineoplastici - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies.  follicular lymphoma (fl) that is refractory to at least two prior  systemic therapies.

यूरोपीय संघ - इतालवी - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agenti antineoplastici - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.